Evaluation of medical isotope production with the accelerator production of tritium (APT) facility

Conference · Thu Jul 10 04:00:00 EDT 1997

OSTI ID:549669

Benjamin, R W ^[1]; Frey, G D; McLean, Jr, D C; Spicer, K M; Davis, S E; Baron, S; Frysinger, J R ^[2]; Blanpied, G; Adcock, D ^[3]

---

1. Westinghouse Savannah River Company, Aiken, SC (United States)
2. Medical Univ. of South Carolina, Charleston, SC (United States)
3. South Carolina Univ., Columbia, SC (United States)

The accelerator production of tritium (APT) facility, with its high beam current and high beam energy, would be an ideal supplier of radioisotopes for medical research, imaging, and therapy. By-product radioisotopes will be produced in the APT window and target cooling systems and in the tungsten target through spallation, neutron, and proton interactions. High intensity proton fluxes are potentially available at three different energies for the production of proton- rich radioisotopes. Isotope production targets can be inserted into the blanket for production of neutron-rich isotopes. Currently, the major production sources of radioisotopes are either aging or abroad, or both. The use of radionuclides in nuclear medicine is growing and changing, both in terms of the number of nuclear medicine procedures being performed and in the rapidly expanding range of procedures and radioisotopes used. A large and varied demand is forecast, and the APT would be an ideal facility to satisfy that demand.

• Research Organization: Westinghouse Savannah River Co., Aiken, SC (United States)
• Sponsoring Organization: USDOE, Washington, DC (United States)
• DOE Contract Number: AC09-96SR18500
• OSTI ID: 549669
• Report Number(s): WSRC-MS--97-0573; CONF-971125--15; ON: DE97053866
• Country of Publication: United States
• Language: English

Related Subjects

07 ISOTOPE AND RADIATION SOURCES
43 PARTICLE ACCELERATORS
55 BIOLOGY AND MEDICINE
BASIC STUDIES
LINEAR ACCELERATORS
MEDICAL SUPPLIES
PRODUCTION
RADIOISOTOPES